Biomarkers related to the diagnosis and progression of Parkinson's disease are significant for early diagnosis including prodromal stage, prognosis, and development of novel therapies. Even now, there are excellent biomarkers, and although diagnostic criteria for the prodromal stage have been proposed, improvement in diagnostic sensitivity and specificity is inevitable. Based on such a background, recent advances in visualization technology using MRI and nuclear medicine, a more in-depth understanding of the effects of gut microbiota on the pathology, advances in blood biomarker measurement technology such as α-synuclein, and skin pathology are something amazing. In this session, symposists who are specialists in each field will provide the latest information and knowledge. We hope young researchers will envision the direction and potential of future research and encourage their research minds.

Biomarkers related to the diagnosis and progression of Parkinson's disease are significant for early diagnosis including prodromal stage, prognosis, and development of novel therapies. Even now, there are excellent biomarkers, and although diagnostic criteria for the prodromal stage have been proposed, improvement in diagnostic sensitivity and specificity is inevitable. Based on such a background, recent advances in visualization technology using MRI and nuclear medicine, a more in-depth understanding of the effects of gut microbiota on the pathology, advances in blood biomarker measurement technology such as α-synuclein, and skin pathology are something amazing. In this session, symposists who are specialists in each field will provide the latest information and knowledge. We hope young researchers will envision the direction and potential of future research and encourage their research minds.

Biomarkers related to the diagnosis and progression of Parkinson's disease are significant for early diagnosis including prodromal stage, prognosis, and development of novel therapies. Even now, there are excellent biomarkers, and although diagnostic criteria for the prodromal stage have been proposed, improvement in diagnostic sensitivity and specificity is inevitable. Based on such a background, recent advances in visualization technology using MRI and nuclear medicine, a more in-depth understanding of the effects of gut microbiota on the pathology, advances in blood biomarker measurement technology such as α-synuclein, and skin pathology are something amazing. In this session, symposists who are specialists in each field will provide the latest information and knowledge. We hope young researchers will envision the direction and potential of future research and encourage their research minds.

Biomarkers related to the diagnosis and progression of Parkinson's disease are significant for early diagnosis including prodromal stage, prognosis, and development of novel therapies. Even now, there are excellent biomarkers, and although diagnostic criteria for the prodromal stage have been proposed, improvement in diagnostic sensitivity and specificity is inevitable. Based on such a background, recent advances in visualization technology using MRI and nuclear medicine, a more in-depth understanding of the effects of gut microbiota on the pathology, advances in blood biomarker measurement technology such as α-synuclein, and skin pathology are something amazing. In this session, symposists who are specialists in each field will provide the latest information and knowledge. We hope young researchers will envision the direction and potential of future research and encourage their research minds.